Annals of Neurology · 2023 · 22 citations · 13 references
Life SciencesGeneticsNeurologyHuman GeneticsMedical GeneticsNeurogeneticsDisease Susceptibility LociGenetic SusceptibilityMultiple SclerosisNeurodegenerative Disease GeneticsNeurodegenerative DiseasesNeurodegenerative DisordersLong-term Neurologic OutcomesMultiple Sclerosis AssociationsMultiple Sclerosis PathologyRelapsing-remitting Multiple Sclerosis Treatment
The minor allele of the genetic variant rs10191329 in the DYSF-ZNF638 locus is associated with unfavorable long-term clinical outcomes in multiple sclerosis patients. We investigated if rs10191329 is associated with brain atrophy measured by magnetic resonance imaging in a discovery cohort of 748 and a replication cohort of 360 people with relapsing multiple sclerosis. We observed an association with 28% more brain atrophy per rs10191329*A allele. Our results encourage stratification for rs10191329 in clinical trials. Unraveling the underlying mechanisms may enhance our understanding of pathophysiology and identify treatment targets. ANN NEUROL 2023;94:1080-1085.
13
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher Chang, Carson C. Chow, Laurent CAM Tellier et al. · GigaScience · 2015 · 14K citations · Full text
Next-generation genotype imputation service and methods
Sayantan Das, Lukas Forer, Sebastian Schönherr et al. · Nature Genetics · 2016 · 4.4K citations · Full text